title: Sertaconazole in the treatment of mycoses: from dermatology to gynecology.
abstract: Sertaconazole is a pharmaceutical product in the form of a cream, gel, powder and solution for dermatological use and vaginal cream, tablets and ovules for gynecological use. It is marketed in 24 countries and registered in a further 22. The active ingredient is 2% sertaconazole nitrate. Sertaconazole nitrate is an azole antifungal agent, with notable antifungal activity. Its molecule has a highly lipophilic fragment. This is a review of the efficacy and safety of all pharmaceutical forms of sertaconazole in order to provide data on vaginal sertaconazole for marketing purposes.
authors: Department of Clinical Pharmacology, Centro de Investigación del Grupo Ferrer, Barcelona, Spain. torres-research@ferrergrupo.com
authors: J
authors: J
authors: Torres
authors: M
authors: M
authors: Márquez
authors: F
authors: F
authors: Camps
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003881:Dermatomycoses / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009181:Mycoses / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D013876:Thiophenes; C061131:sertaconazole